Hennion & Walsh Asset Management, Inc.
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1861642
Parsippany, NJ
Position in MDGL
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$4,662,873
+$152,656 QoQ
Shares Held
8,684
+0.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#121
of 411 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $200,308,891 across 60 Biotechnology names. MDGL ranks #13 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
48,019 | $11,571,138 | |
| 2 | CELC |
Celcuity Inc.
|
100,368 | $10,500,500 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
276,696 | $10,182,412 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
171,470 | $9,741,210 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
342,883 | $7,495,422 | |
| 6 | QURE |
uniQure N.V.
|
142,113 | $6,545,724 | |
| 7 | KURA |
Kura Oncology, Inc.
|
568,845 | $6,240,229 | |
| 8 | ARDX |
Ardelyx, Inc.
|
1,211,690 | $6,179,619 |
All Filings in MDGL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,662,873 | 8,684 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $4,510,217 | 8,616 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,753,641 | 8,163 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $5,892,405 | 12,847 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,835,962 | 12,675 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,646,511 | 11,009 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $3,056,077 | 9,904 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $4,014,565 | 18,917 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $5,697,613 | 20,337 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $8,630,198 | 32,318 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $6,230,137 | 26,926 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $5,253,350 | 35,972 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $8,684,214 | 37,594 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $11,308,454 | 46,679 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $13,334,955 | 45,943 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,314,944 | 51,007 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,247,771 | 59,343 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $7,234,780 | 73,734 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $5,869,177 | 69,261 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,899,353 | 73,936 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,165,869 | 73,564 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,461,843 | 72,342 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||